Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
163.79 | -21.82% | -11.49% | 290,014.27 | 3.79% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
311.29 | -11.92% | -3.1% | 166,968.34 | 2.89% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
64.78 | 26.38% | 36.06% | 80,778.67 | 4.75% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
217.51 | -10.14% | 5.81% | 31,668.78 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
82.44 | 138.05% | 216.12% | 15,653.69 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
53.76 | 106.98% | 155.97% | 11,887.19 | 0% | 27.62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
76.97 | 0% | 0% | 8,775.14 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
107.19 | 0% | 0% | 6,711.91 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
13.63 | 0% | 0% | 3,296.42 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
24.44 | 0% | 0% | 2,989.63 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
10.40 | 0% | 0% | 2,958.8 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
17.05 | 0% | 0% | 2,816.72 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
42.56 | 0% | 0% | 2,805.15 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
47.83 | -94.47% | -74.71% | 2,215.07 | 0% | 0% |
|
NasdaqGM:ARDX
Ardelyx
|
8.72 | 0% | 0% | 2,040.28 | 0% | 0% |
